A late immune response with delayed IFN production may promote this maladaptive process, whereas a rapid and orderly virus clearance through a timely initial burst of IFN production may avert further complications, in a similar manner to that described in COVID-19 [21,22]. This evidence concerns the gene IFNA1 and COVID-19.